Blood clots are treated primarily with anticoagulant medications (blood thinners) that stop the clot from growing while your body’s own enzymes gradually dissolve it. Most clots take about three months of active treatment to resolve, though the timeline varies. In emergency situations like a stroke or massive lung clot, doctors use more aggressive interventions to break up or physically remove the blockage.
The right treatment depends on where the clot is, how large it is, and how much danger it poses. Here’s what each approach involves and what to expect.
Blood Thinners: The First-Line Treatment
For the vast majority of blood clots, including deep vein thrombosis (DVT) in the legs and pulmonary embolism (PE) in the lungs, anticoagulant medications are the standard treatment. These drugs don’t actually dissolve the clot directly. They work by blocking key steps in the clotting process, which prevents the clot from getting bigger and stops new clots from forming. With the clot stabilized, your body’s natural repair system gradually breaks it down over weeks to months.
Current guidelines recommend direct oral anticoagulants (DOACs) over the older drug warfarin for most patients. DOACs work by blocking specific clotting proteins in the blood and are taken as a daily pill. Warfarin works differently, by blocking vitamin K, which your body needs to make clotting factors. The practical difference for patients: warfarin requires regular blood tests to check that the dose is right, along with dietary restrictions around vitamin K-rich foods like leafy greens. DOACs don’t require routine monitoring or food restrictions.
In terms of outcomes, the two approaches perform similarly. Five-year recurrence rates are about 10% for both, and major bleeding rates are comparable at roughly 12 to 14%. The convenience advantage of DOACs is the main reason they’ve become the preferred option.
For patients who need faster-acting treatment, such as those hospitalized with a large clot, injectable forms of blood thinners (typically a type of heparin) are given first, then transitioned to an oral medication. The initial treatment phase lasts three to six months. After that, your doctor may recommend continuing anticoagulation longer if the clot occurred without an obvious trigger or if you have an ongoing risk factor.
Clot Busters for Emergencies
When a blood clot causes an acute, life-threatening event, blood thinners alone aren’t fast enough. In these cases, doctors use thrombolytic drugs, commonly called “clot busters,” which actively dissolve the clot rather than waiting for your body to do it. The most well-known is tissue plasminogen activator (tPA), which is used during strokes caused by a blocked blood vessel. It must be given within three hours of stroke onset to be effective, which is why getting to a hospital fast matters enormously.
The tradeoff with clot busters is bleeding risk. Because these drugs supercharge the body’s clot-dissolving activity, they can cause dangerous bleeding, especially in the brain. Earlier versions of these drugs were even riskier because they prevented clotting throughout the entire body. Modern formulations use lower, more targeted doses that reduce this danger, but the risk remains significant enough that doctors reserve thrombolytics for situations where the clot itself is the more immediate threat to life.
Catheter-Based Procedures
For large, dangerous clots, particularly in the lungs, doctors can intervene directly using catheter-based procedures. A thin tube is threaded through a blood vessel to the site of the clot, where one of two things happens: the clot-busting drug is delivered right at the blockage (catheter-directed thrombolysis), or a specialized device physically pulls the clot out (mechanical thrombectomy).
Both approaches are effective. Recent trial data comparing the two in patients with intermediate-to-high-risk pulmonary embolism found no difference in mortality or major bleeding. Mechanical thrombectomy did show a practical advantage, though: patients spent less time in the ICU and had lower hospital readmission rates. These procedures are reserved for cases where the clot is large enough to strain the heart or where blood thinners alone aren’t controlling the situation.
Filters That Catch Clots in Transit
Some people can’t take blood thinners safely, whether due to a recent surgery, active bleeding, or another medical reason. In these cases, doctors can place a small metal filter inside the inferior vena cava, the large vein that carries blood from your lower body back to your heart. The filter acts as a net, catching clots that break free from your legs before they reach your lungs.
These filters don’t treat the clot itself. They’re a safety measure to prevent a pulmonary embolism while the underlying clot situation is managed. Interestingly, a meta-analysis of over 800 patients found that adding a filter to anticoagulation therapy didn’t reduce the rate of recurrent PE at three months. In trauma patients, prophylactic filter placement was actually associated with higher rates of nonfatal clots. For these reasons, filters are typically used only when anticoagulation truly isn’t an option, and retrievable filters are removed once the patient can safely take blood thinners again.
What Recovery Looks Like
Active treatment for a blood clot generally takes about three months, but full recovery is more individual. Some people feel better within weeks, while others deal with lingering symptoms for much longer. The National Blood Clot Alliance advises that pushing yourself aggressively through pain and swelling won’t speed up recovery, but being active won’t make things worse either. Gentle, regular movement is encouraged.
A significant long-term concern after DVT is post-thrombotic syndrome (PTS), a condition where the clot damages the vein’s valves, causing chronic swelling, pain, and sometimes skin changes in the affected leg. Without any intervention, roughly half of people who have a DVT in their upper leg develop some degree of PTS within two years. Earlier open-label studies suggested that wearing knee-high compression stockings (30 to 40 mmHg pressure) within a few weeks of diagnosis could cut that rate in half. However, the largest and most rigorous trial, which used placebo stockings as a control, found no significant difference. The current view is that compression stockings are reasonable for managing swelling and discomfort but may not change whether PTS ultimately develops.
Symptoms That Signal a Medical Emergency
A blood clot becomes most dangerous when it travels to the lungs. Shortness of breath is often the first warning sign of a pulmonary embolism. Other symptoms include sharp or stabbing chest pain that worsens when you breathe deeply, a sudden cough (sometimes with blood), a rapid heart rate, clammy or bluish skin, dizziness, and fainting. These symptoms can develop suddenly in someone who already has a known DVT or in someone who had no idea they had a clot at all.
DVT itself typically shows up as swelling, warmth, and pain in one leg, usually the calf or thigh. The leg may look red or discolored. Not all DVTs cause obvious symptoms, which is part of what makes them dangerous. If you notice unexplained leg swelling along with any of the lung-related symptoms above, that combination warrants emergency care.
What Won’t Get Rid of a Blood Clot
No home remedy, supplement, or lifestyle change will dissolve an existing blood clot. Staying hydrated, eating well, and exercising are all good for your vascular health and can reduce your risk of future clots, but they have no effect on a clot that has already formed. Blood clots require medical treatment. The body can dissolve small clots on its own over time, but without anticoagulation to prevent growth, a clot can expand or break loose before the body has a chance to clear it. If you suspect you have a blood clot, treatment needs to start as soon as possible to prevent complications.